Nomura Holdings Inc Next Cure, Inc. Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $295,887 - $472,381	-51,910 Reduced 50.0%	51,910 $313,000
Q2 2021 Aug 16, 2021	BUY	$7.6 - $10.28 $191,520 - $259,055	25,200 Added 32.05%	103,820 $833,000
Q1 2021 May 17, 2021	BUY	$9.81 - $13.88 $17,854 - $25,261	1,820 Added 2.37%	78,620 $797,000
Q4 2020 Feb 16, 2021	BUY	$9.47 - $12.43 $727,296 - $954,624	76,800 New	76,800 $840,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.